Name: BIO-B Income Statement - Bio-rad Laboratories Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

BIO-B - Bio-rad Laboratories, Inc.

USD | NYSE

BIO-B Income Statement - Bio-rad Laboratories Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q4 FY 23	Q3 FY 23	Q2 FY 23	Q1 FY 23	Q4 FY 22	Q3 FY 22	Q2 FY 22	Q1 FY 22	Q4 FY 21	Q3 FY 21	Q2 FY 21	Q1 FY 21	Q4 FY 20	Q3 FY 20	Q2 FY 20	Q1 FY 20	Q4 FY 19	Q3 FY 19	Q2 FY 19	Q1 FY 19	Q4 FY 18	Q3 FY 18	Q2 FY 18	Q1 FY 18	Q4 FY 17	Q3 FY 17	Q2 FY 17	Q1 FY 17	Q4 FY 16	Q3 FY 16	Q2 FY 16
Revenues
Revenues	592.1	693.2	653.0	651.6	585.4	667.5	649.7	638.5	610.8	681.1	632.1	681.1	676.8	730.2	680.8	691.1

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018	FY2017	FY2016	FY2015	FY2014	FY2013	FY2012	FY2011	FY2010	FY2009
Revenues
Revenues	2,589.9	2,583.2	2,566.5	2,671.2	2,802.2	2,922.5	2,545.6	2,311.7	2,289.4	2,160.2	2,068.2	2,019.4	2,175.0	2,132.7	2,069.2	2,073.5	1,927.1	1,784.2
Cost of Revenue	1,246.6	1,243.3	1,187.6	1,244.3	1,234.9	1,284.4	1,107.7	1,054.7	1,066.3	972.5	929.7	897.8	996.5	954.2	914.1	894.7	835.6	784.4
Gross Profit	1,343.3	1,339.9	1,378.9	1,426.9	1,567.3	1,638.1	1,437.9	1,257.0	1,223.1	1,187.8	1,138.5	1,121.7	1,178.5	1,178.5	1,155.2	1,178.8
Operating Expenses
Research & Development	265.0	275.6	295.9	247.4	256.9	260.6	217.8	202.7	199.2	250.2	205.7	193.0	220.3	211.0	209.2
Operating Income
Operating Income	57.6	47.2	269.0	337.8	482.6	500.3	421.3	229.7	(103.3)	119.3	55.7	166.7	150.0	169.5
Non-Operating
Interest Income	80.3	95.5	82.0	100.9	58.1	18.9	18.2	30.5	26.6	19.1	14.7	10.1	13.5	13.4	11.4
Tax & Net
Income Tax Expense	53.5	235.6	(498.3)	(212.8)	(1,076.7)	1,194.8	1,103.8	502.4	147.0	(24.4)	15.6	36.6	42.7	34.6	64.4
Per Share
EPS Basic	6.26	27.87	(65.36)	(21.82)	(121.79)	142.61	128.13	58.93	12.25	4.12	0.88	3.74	3.08	2.72	5.85	6.39
Supplementary Data
EBITDA	-	212.6	420.6	483.7	619.9	637.9	559.9	363.9	34.8	268.0	198.6	298.5	299.9	316.7	394.6	426.2

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

Operating Expenses
Research & Development	62.9	70.3	71.3	60.5	73.5	79.6	91.0	58.9	66.4	63.9	43.5	65.0	75.0	66.2	66.8	64.3	59.5	58.9	64.5	63.4	73.9	56.9	59.5	52.0	49.3	57.1	47.9	50.1	47.6	53.1	49.2	47.5	49.4	76.0	62.1	62.6	49.5	57.4	49.9	49.8
Selling General & Administrative	212.4	221.0	206.8	207.7	208.8	204.0	200.4	194.7	214.9	207.1	201.2	207.8	225.6	212.2	211.1	207.8
Selling & Marketing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General & Administrative	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Depreciation & Amortization	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of Intangibles	5.9	6.3	7.3	5.2	5.0	5.1	5.3	5.3	5.5	5.7	6.2	5.9	6.0	6.1	6.2	6.3	6.3
Other Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

Operating Income
Operating Income	34.1	(118.9)	65.3	77.1	23.7	58.4	64.5	101.5	44.6	95.3	90.9	89.6	61.9	118.7	94.6	122.9	146.4	117.9	156.8	124.8	100.9	185.6	109.6	51.7	74.4	59.2	57.5	56.4	56.6	(227.1)	36.3	43.8	43.6	56.0	38.8	(1.7)	26.2	(20.6)	28.1	22.5

Non-Operating
Interest Income	21.0	30.9	13.7	14.7	36.2	16.0	15.4	16.6	34.0	16.8	17.3	16.5	50.3	12.4	8.0	5.5	32.2	(0.4)	0.3	0.7	18.3	3.6	1.8	10.0	2.8	3.1	4.1	3.8	19.5	5.7	2.6	16.2	2.1	4.6	1.4	12.0	1.1	1.6	1.3	10.6
Interest Expense	12.3	12.1	12.3	12.6	12.0	12.2	12.1	12.3	12.3	12.3	12.4	12.3	12.3	11.7	11.7	10.7	4.0	0.4
Income From Equity Investments	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Non-Operating Income	24.2	28.6	8.3	16.2	37.2	19.6	17.9	18.2	34.6	19.1	20.4	16.5	50.4	2.3	3.1	6.7	32.6
Pre-Tax Income	(689.8)	929.2	(431.1)	414.0	83.4	(908.9)	861.6	(2,786.3)	491.1	428.4	137.1	(1,500.4)	84.8	1,091.4	(207.3)	(1,220.2)

Tax & Net
Income Tax Expense	(162.7)	209.2	(89.2)	96.2	19.4	(193.1)	208.4	(620.8)	107.2	78.7	30.8	(338.2)	15.9	263.6	(44.5)	(295.1)	(1,000.7)	(461.8)	1,094.2	242.7	319.8	241.8	369.6	279.5	212.8	145.9	(76.4)	170.8	262.1	(212.7)	80.8	72.0	206.9	(36.8)	8.5	(3.9)	7.7	(5.5)	4.3	8.9
Net Income From Continuing Ops	(527.1)	720.0	(341.9)	317.8	64.0	(715.8)	653.2	(2,165.5)	383.9	349.7	106.3	(1,162.3)	69.0	827.8	(162.8)	(925.1)	(3,367.3)
Net Income From Discontinued Ops	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	(527.1)	720.0	(341.9)	317.8	64.0	(715.8)	653.2	(2,165.5)	383.9	349.7	106.3	(1,162.3)	69.0	827.8	(162.8)	(925.1)	(3,367.3)
Net Income Attributable To Parent	(527.1)	720.0	(341.9)	317.8	64.0	(715.8)	653.2	(2,165.5)	383.9	349.7	106.3	(1,162.3)	69.0	827.8	(162.8)	(925.1)
Less: Minority Interest	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Less: Preferred Dividends	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income To Common Shareholders	(527.1)	720.0	(341.9)	317.8	64.0	(715.8)	653.2	(2,165.5)	383.9	349.7	106.3	(1,162.3)	69.0	827.8	(162.8)

Per Share
EPS Basic	(19.55)	-	(12.70)	11.67	2.29	-	23.37	(76.26)	13.46	-	3.65	(39.59)	2.33	-	(5.48)	(31.05)	(112.50)	-	131.75	30.71	32.77	-	44.24	32.59	22.97	-	(8.68)	20.08	29.03	-	9.02	8.99	22.05	-	0.74	0.17	0.42	-	0.63	0.61
EPS Diluted	(19.55)	-	(12.70)	11.67	2.29	-	23.34	(76.26)	13.45	-	3.64	(39.59)	2.32	-	(5.48)	(31.12)	(112.50)	-
Shares Basic	27.0	-	26.9	27.2	27.9	-	27.9	28.4	28.5	-	29.1	29.4	29.6	-	29.7	29.8	29.9	-
Shares Diluted	27.0	-	26.9	27.2	28.0	-	28.0	28.4	28.5	-	29.2	29.4	29.7	-	29.7	29.8	29.9	-

Supplementary Data
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	108.0	-	-	-	89.5	-	-	-	77.9	-	-	-	59.9	-	-	-
EBIT	34.1	(118.9)	65.3	77.1	23.7	58.4	64.5	101.5	44.6	95.3	90.9	89.6	61.9	118.7	94.6	122.9	146.4	117.9	156.8